Sulopenem

DRUG3 trials

Sponsors

Iterum Therapeutics, International Limited

Conditions

Complicated Urinary Tract InfectionsIntra Abdominal InfectionsIntraabdominal InfectionsPyelonephritis AcuteUrinary Tract Infections

Phase 1

Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents

WithdrawnNCT04700787

Iterum Therapeutics, International LimitedIntraabdominal Infections, Pyelonephritis Acute, Urinary Tract Infections

Start: 2021-04-30End: 2022-04-04Updated: 2022-06-13

Phase 3

Sulopenem Versus Ertapenem for Complicated Intra-abdominal Infection (cIAI)

CompletedNCT03358576

Iterum Therapeutics, International LimitedIntra Abdominal Infections

Start: 2018-09-18End: 2019-10-02Updated: 2020-12-01

Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults

CompletedNCT03357614

Iterum Therapeutics, International LimitedComplicated Urinary Tract Infections

Start: 2018-09-18End: 2019-12-14Updated: 2020-12-29

Related Papers

Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial

Clinical Infectious Diseases2022-09-0735 citations